Cytokeratins Tools in Oncology

The first chapters of the volume "Cytokeratins - Tools in Oncology" discuss multiple functions of cytokeratins in organization of the intermediary filaments in normal intestine and liver as well as microfold L cells and the usability of cytokeratins 7, 8 and 20 in tumor diagnosis in detail...

Full description

Saved in:
Bibliographic Details
Other Authors: Hamilton, Gerhard (Editor)
Format: Electronic Book Chapter
Language:English
Published: IntechOpen 2012
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_65626
005 20210420
003 oapen
006 m o d
007 cr|mn|---annan
008 20210420s2012 xx |||||o ||| 0|eng d
020 |a 1888 
020 |a 9789535100478 
020 |a 9789535168188 
040 |a oapen  |c oapen 
024 7 |a 10.5772/1888  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MJCL  |2 bicssc 
100 1 |a Hamilton, Gerhard  |4 edt 
700 1 |a Hamilton, Gerhard  |4 oth 
245 1 0 |a Cytokeratins  |b Tools in Oncology 
260 |b IntechOpen  |c 2012 
300 |a 1 electronic resource (172 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a The first chapters of the volume "Cytokeratins - Tools in Oncology" discuss multiple functions of cytokeratins in organization of the intermediary filaments in normal intestine and liver as well as microfold L cells and the usability of cytokeratins 7, 8 and 20 in tumor diagnosis in detail. Epithelial to mesenchymal transition as a mechanism important in pathogenesis is touched in another chapter, followed by several articles dealing with the role of cytokeratins for detection of disseminated tumor cells and as response markers during chemotherapy. This book is therefore destined to all cancer researchers and therapists who want to understand the diagnostic application of cytokeratins in histology and, especially, the use of anti-cytokeratin antibodies to identify viable residual tumor cells accounting for a higher risk of tumor recurrence or cancer cells responding to chemotherapy, respectively. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Oncology  |2 bicssc 
653 |a Oncology 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/1428/authors_book/authors_book.pdf  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/65626  |7 0  |z DOAB: description of the publication